Original Research
Published on 11 Nov 2025
Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A
in Cancer Immunity and Immunotherapy
- 623 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 11 Nov 2025
in Neonatology
Review
Published on 11 Nov 2025
in Carbon-Based Heterostructures
Original Research
Published on 11 Nov 2025
in AI in Finance
Review
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Cellular Biochemistry
Systematic Review
Published on 11 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Opinion
Published on 11 Nov 2025
in Cancer Genetics
Case Report
Published on 11 Nov 2025
in Obstetric and Pediatric Pharmacology
Clinical Trial
Published on 11 Nov 2025
in Cardiovascular Endocrinology
Policy and Practice Reviews
Published on 11 Nov 2025
in Life-Course Epidemiology and Social Inequalities in Health
Review
Published on 11 Nov 2025
in Mucosal Immunity
Original Research
Published on 11 Nov 2025
in Biomaterials
Original Research
Published on 11 Nov 2025
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 11 Nov 2025
in Pediatric Urology